BlossomHill Therapeutics, Inc. (BLSM) — Stock Valuation & Research

Blossomhill Therapeutics, Inc. is a biopharmaceutical company. It engages in the development of small molecule medicines for unmet medical needs in cancer treatment. The company was founded in June 2020 and is headquartered in San Diego, CA.

BLSM key statistics

Price$12.41
Market cap$360.9M
SectorHealthcare
IndustryBiotechnology
ExchangeNASDAQ
52-week range12.275-27.99
Beta0

Explore BLSM's full valuation scorecard, price history, financial statements, insider and institutional ownership, and peer comparison on this page — free, no login required.